Andreas Poschenrieder

First-in-Human Experience of CXCR4-Directed Endoradiotherapy with ¹⁷⁷Lu- and ⁹⁰Y-Labeled Pentixather in Advanced-Stage Multiple Myeloma with Extensive Intra- and Extramedullary Disease

Ken Herrmann, Margret Schottelius, Constantin Lapa et al. · Journal of Nuclear Medicine · 2015 · 269 citations · Full text

Medicine, Oncology, Radiation Oncology +16

[¹⁷⁷Lu]pentixather: Comprehensive Preclinical Characterization of a First CXCR4-directed Endoradiotherapeutic Agent

Margret Schottelius, Theresa Osl, Andreas Poschenrieder et al. · Theranostics · 2017 · 132 citations · Full text

Medicine, Oncology, Pharmacology +17

Imaging the Cytokine Receptor CXCR4 in Atherosclerotic Plaques with the Radiotracer ⁶⁸Ga-Pentixafor for PET

Fabien Hyafil, Jaroslav Pelisek, Iina Laitinen et al. · Journal of Nuclear Medicine · 2016 · 110 citations · Full text

Medicine, Cardiology, Nuclear Medicine +16

The influence of different metal-chelate conjugates of pentixafor on the CXCR4 affinity

Andreas Poschenrieder, Margret Schottelius, Markus Schwaiger et al. · EJNMMI Research · 2016 · 42 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

First 18F-Labeled Pentixafor-Based Imaging Agent for PET Imaging of CXCR4 Expression In Vivo

Andreas Poschenrieder, Theresa Osl, Margret Schottelius et al. · Tomography · 2016 · 37 citations · Full text

Medicine, Nuclear Medicine, Oncology +17